Share Name Share Symbol Market Type Share ISIN Share Description
Omega Dia LSE:ODX London Ordinary Share GB00B1VCP282 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 17.875p 17.50p 18.25p 17.875p 17.875p 17.875p 37,206 07:55:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 14.2 0.7 1.1 16.3 22.68

Omega Diagnostics Share Discussion Threads

Showing 1901 to 1923 of 1925 messages
Chat Pages: 77  76  75  74  73  72  71  70  69  68  67  66  Older
DateSubjectAuthorDiscuss
24/7/2017
07:36
I am afraid we will have to differ on this Earnings per share have gone down , and my previous comments re flatlining have proved valid I don't like the BOD But then again .... I am hard to please
buywell3
23/7/2017
20:40
Or they have enough sense only to dilute as much as is absolutely necessary and use other means where possible. NIRP from the ECB has put some oomph into German property prices. Note they didn't follow that procedure for any other geography, only the one with the best price dynamics. Someone at ODX has some snouse.
p1nkfish
23/7/2017
15:40
Another view from ground level One might think the sale of the premises was because more cash is needed than was raised I stand stage left ....... waiting , Cobra like
buywell3
23/7/2017
13:45
longshanks - it's the 'less/greater than' signs - advfn is interpreting them as HTML. You need to replace them before pasting either with the actual words, or with '&-l-t-;' and '&-g-t-;'[between the quotes, without the dashes!]
supernumerary
23/7/2017
12:45
Malawi, Uganda and Zimbabwe, almost half the people with CD4 count
longshanks
23/7/2017
12:45
Don't know what is going on...Here is the rest:
longshanks
23/7/2017
12:43
Whoops: failed to post full quote.2.4 Role of CD4 cell count testing in identifying and managing people with advanced HIV diseaseThe 2016 WHO consolidated ARV guidelines recommend starting ART regardless of CD4 cell count and that the use of CD4 cell count for ART response monitoring can be stopped in settings where routine viral load monitoring is available and people are stable on ART (29). However, CD4 cell count testing at baseline for all people living with HIV remains important (44). Relying on clinical staging alone risks missing substantial numbers of people living with HIV with severe immune suppression. In a study from Kenya, Malawi, Uganda and Zimbabwe, almost half the people with CD4 count
longshanks
23/7/2017
12:39
Omega are attending HIV conferences over the next few weeks. Good timing as the WHO has just provided this update to their guidance from June 2016.hTTp://apps.who.int/iris/bitstream/10665/255884/1/9789241550062-eng.pdf?ua=1This section is of notable importance to ODX holders.2.4 Role of CD4 cell count testing in identifying and managing people with advanced HIV diseaseThe 2016 WHO consolidated ARV guidelines recommend starting ART regardless of CD4 cell count and that the use of CD4 cell count for ART response monitoring can be stopped in settings where routine viral load monitoring is available and people are stable on ART (29). However, CD4 cell count testing at baseline for all people living with HIV remains important (44). Relying on clinical staging alone risks missing substantial numbers of people living with HIV with severe immune suppression. In a study from Kenya, Malawi, Uganda and Zimbabwe, almost half the people with CD4 count
longshanks
21/7/2017
20:33
Given the buoyancy in the German property market and the use they can put the cash to, I think ODX did the right thing with the sale and leaseback over there. Once they prove they have allocated the cash wisely for growth we will see new highs. Frustrating wait.
p1nkfish
21/7/2017
16:26
The world would be in a bad state without us snakes We perform very important tasks
buywell3
21/7/2017
16:17
Call it a striking cobra if you want but a snake is still a snake.
longshanks
21/7/2017
14:13
A striking cobra eh....fantastic! That gave me a good laugh for a Friday afternoon :o)) Well done longshanks, I also try to nag CEOs into including smaller holders for a portion of any fundraising. You may well have grabbed his attention as often it's something they don't even consider.
rivaldo
20/7/2017
16:42
I wait in the wings ready to leap out and strike with the speed of a striking cobra When the time is right I might join the party
buywell3
20/7/2017
10:24
Probably because the BIG shareholders would not take the lot Don't kid yourself, ask yourself why ?
buywell3
17/7/2017
22:16
All credit to the company for including us PIs in the offer, many don't. True, the outcome must be regarded as mildly disappointing, but we now have a share of a better capitalized company and better prospects of real progress in the near future. Certainly hope so.
dozey3
17/7/2017
21:08
poppa - haven't checked the numbers but OOs in these circumstances are usually more to do with disapplicaton of preemption rights than with giving opportunities to PIs.
supernumerary
17/7/2017
19:51
I requested ten times my entitlement under the excess facility and am happy to have received all I asked for. I'm not concerned about your small minded 'savings' angle, I saw it as a good opportunity to add to my holding. I wonder how many of the folk who were happy to pay 25p not long ago either didn't take up all their entitlement or didn't use the excess facility.
columbarius
17/7/2017
18:57
Lets say you hold 100,000 shares. They've got a market value of just under £20,000. On a 1 for 19 basis in the open offer, you were entitled to 5,263 shares at 18p. Total cost = £947. To buy those 5,263 shares in the market at 20p would cost £1,053. A saving of £106 equates to 0.5% of the value of a shareholding worth £20,000. 'Hardly worth bothering with. Anyway, at least they gave us the opportunity, which would have cost a lot in fees. So we have to thank them for that.
poppa wobbler
17/7/2017
15:16
Positive news is the key and to be fair there hasn't been an abundance of it from Omega over the last few years but everything is being ramped up for growth so hopefully exciting times around the corner, just not too sure how long the bend is though! More twitter activity of late might be an indication of happier times ahead for us 👍 Https://twitter.com/OmegaDiagnostic
hyperboreus
17/7/2017
15:05
Hyperboreus, It is disappointing, the company would have expected a higher take up but perhaps the shareholders were disappointed with the share price drop to get the placing away, but you also need available funds, I was only prepared to sell one of my holdings to free up funds in my SIPP....Lets see if they release any news in the next few weeks....
barrywhit
17/7/2017
14:55
It only equates to a shortfall of just over £336,000 which I am sure the Directors will be disappointed with and will probably regret giving existing shareholders a go with an Open Offer' For what it is worth I did pile in barry so quite happy on a personal level that I will receive everything I asked for 😎
hyperboreus
17/7/2017
14:39
Only 67.4% taken up in the open share offer........I took 90% of my allocation, I was expecting a higher percentage to be taken up.....
barrywhit
17/7/2017
09:55
Two days to go to the completion of the fundraising. It seems very quiet here given the importance of this week.
verger
Chat Pages: 77  76  75  74  73  72  71  70  69  68  67  66  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20170725 04:56:07